Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis. (Q33942782)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.
scientific article

    Statements

    Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis (English)
    Scientific Advisory Group and Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit